Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers
2011

Exhaled Breath Condensate pH as a Biomarker of COPD Severity in Ex-Smokers

Sample size: 273 publication 10 minutes Evidence: moderate

Author Information

Author(s): Papaioannou Andriana I, Loukides Stelios, Minas Markos, Kontogianni Konstantina, Bakakos Petros, Gourgoulianis Konstantinos I, Alchanatis Manos, Papiris Spyros, Kostikas Konstantinos

Primary Institution: University of Thessaly Medical School, Larissa, Greece

Hypothesis

The study aims to measure EBC pH levels in COPD patients and evaluate associations with functional parameters based on smoking status.

Conclusion

EBC pH is lower in COPD patients compared to controls and is related to disease severity, particularly in ex-smokers.

Supporting Evidence

  • EBC pH was significantly lower in COPD patients compared to controls.
  • Ex-smokers with COPD had lower EBC pH compared to current smokers.
  • EBC pH levels were associated with static hyperinflation and air trapping in ex-smokers.

Takeaway

The acidity of breath can show how severe COPD is, especially in people who used to smoke.

Methodology

EBC was collected from 161 COPD patients and 112 controls, with pH measured after Argon deaeration and pulmonary function tests conducted.

Potential Biases

Current smoking may obscure the underlying inflammatory processes in COPD.

Limitations

The study may have a large variation in EBC pH measurements, limiting clinical utility for individual patients.

Participant Demographics

161 COPD patients (75 current smokers, 86 ex-smokers) and 112 controls matched for age and gender.

Statistical Information

P-Value

p < 0.001

Confidence Interval

[7.02, 7.44]

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1465-9921-12-67

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication